What should I say if my kids worry about getting lupus?
How to talk to your child about their risk of lupus Many people living with lupus worry about how...
Stories & News
A New Frontier in Lupus Treatment: One Researcher’s Hope for Children
Engineered cell therapies have been generating significant excitement as researchers explore whether advances that have transformed some cancer treatments...
How can I host my own fundraiser?
Hosting your own fundraising event can make a tremendous difference to accelerate scientific discovery and transforming lives. And, you...
Lupus and Allied Diseases Association Donates $200,000 to Accelerate Lupus Research Progress at 2026 Lupus Charity Golf Classic
The Lupus Research Alliance shares its heartfelt appreciation with the Lupus and Allied Diseases Association, Inc. (LADA) for its generous $200,000...
Published Paper Highlights the Potential of LRA’s Lupus Nexus to Drive Meaningful Scientific Discovery and Clinical Development
The Lupus Nexus – the unique lupus registry, biorepository, and information exchange platform spearheaded by the Lupus Research Alliance...
Liv Snell: Taking Back Control, One Mile at a Time
Loss of control is one of the most challenging “side effects” of living with a chronic disease like lupus....
Can the Sun Make Lupus Worse? Sun Safety Tips with Dr. Jillian Richmond
As the summer is in full swing, it’s important for people with lupus to pay close attention to sun...
Emmitt Henderson III: Finding Strength in Building Community
While 90% of people with lupus are women, the 10% of men also impacted by lupus face the same roller-coaster experience and often struggle more to find community.
Like too many men, Emmitt...
House Passes Bill Supporting NIH Research Funding and Lupus ABC
Momentum continues to build in Congress to strengthen federal investment in biomedical research, with key House appropriations bills advancing...
Support Progresses for Medical Research Programs in Congress
Momentum is building across Congress and the research community in strong support of increased federal investment in medical research at both...
Late-Breaking Data at EULAR Shows Investigational Drug Nipocalimab Significantly Reduces Disease Activity in Lupus
The Lupus Research Alliance is encouraged by positive late-breaking Phase 2 data with nipocalimab, an investigational drug in development by Johnson & Johnson showing significantly reduced disease activity in...
Positive Results of Phase 3 Dapirolizumab Pegol Trial in Systemic Lupus Erythematosus Shown in Published Paper
The Lupus Research Alliance welcomes additional positive results from the Phase 3 PHOENYCS GO study showing that combined with...